Use of Perflubron to Enhance Lung Gene Expression: Safety and Initial Efficacy Studies in Non-Human Primates
Open Access
- 31 January 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (1) , 8-15
- https://doi.org/10.1006/mthe.2001.0507
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patientsGene Therapy, 2000
- Engineering Viral Vectors to Subvert the Airway Defense ResponseAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Basolateral Localization of Fiber Receptors Limits Adenovirus Infection from the Apical Surface of Airway EpitheliaJournal of Biological Chemistry, 1999
- PERFLUOROCHEMICAL LIQUID-ENHANCED ADENOVIRAL VECTOR DISTRIBUTION AND EXPRESSION IN LUNGS OF SPONTANEOUSLY BREATHING RODENTSExperimental Lung Research, 1999
- Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway EpitheliaHuman Gene Therapy, 1998
- Nonspecific Inflammation Inhibits Adenovirus-Mediated Pulmonary Gene Transfer and Expression Independent of Specific Acquired Immune ResponsesHuman Gene Therapy, 1998
- Effects of bronchopulmonary inflammation induced by Pseudomonas aeruginosa on adenovirus-mediated gene transfer to airway epithelial cells in miceGene Therapy, 1998
- The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitroGene Therapy, 1998
- Role of Alveolar Macrophages in Rapid Elimination of Adenovirus Vectors Administered to the Epithelial Surface of the Respiratory TractHuman Gene Therapy, 1997
- In Vitro Assessment of Variables Affecting the Efficiency and Efficacy of Adenovirus-Mediated Gene Transfer to Cystic Fibrosis Airway EpitheliaHuman Gene Therapy, 1996